The GLP-1 oral liquid formulation is one example of a non-injectable approach
Piening A, Ebert E, Gottlieb C, Khojandi N, Kuehm LM, Hoft SG, et al
Taste disturbance is not listed among the common adverse reactions in the Zepbound prescribing information, which means it either did not occur frequently enough in clinical trials to warrant inclusion or was not systematically captured as a distinct adverse event
The company is led by seasoned industry professionals with extensive experience in all phases of asset acquisition and drug development and commercialization
Holland JE, Bennett AE, Newton AC, White PJ, McKenzie BM, George TS, Pakeman RJ, Bailey JS, Fornara DA, Hayes RC
Patients using Ozempic are advised to monitor symptoms closely and consult healthcare providers for preventative measures and treatment options if infections arise